Rocket Pharmaceuticals In... (RCKT)
NASDAQ: RCKT
· Real-Time Price · USD
3.04
0.01 (0.33%)
At close: Aug 15, 2025, 3:59 PM
3.02
-0.68%
After-hours: Aug 15, 2025, 07:30 PM EDT
Rocket Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 9.19M | n/a | n/a | n/a | 10.31M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 2.54M | 2.99M | n/a | 2.39M | 2.34M | 2.25M | 5.16M | 1.76M | 1.72M | 1.67M | 1.78M | 1.64M | 1.57M | 1.3M | 3.19M | 800K | 700K | 674K |
Gross Profit | -2.54M | -2.99M | 4.59M | -2.39M | -2.34M | -2.25M | 5.16M | -1.76M | -1.72M | -1.67M | -1.78M | -1.64M | -1.57M | -1.3M | -3.19M | -800K | -700K | -674K |
Operating Income | -71.15M | -64.39M | -62.69M | -69.42M | -73.71M | -67.38M | -63.28M | -65.43M | -68.76M | -62.19M | -69.08M | -58.49M | -54.21M | -42.56M | -44.33M | -49.65M | -34.05M | -39.22M |
Interest Income | 2.7M | 3.53M | 2.84M | 3.18M | 4.54M | 5.79M | 4.09M | 4M | 3.52M | 4.33M | 2.33M | 1.35M | 669K | 623K | 849K | 806K | 501K | 272K |
Pretax Income | -68.92M | -61.33M | -60.33M | -66.72M | -69.65M | -62.05M | -59.66M | -61.9M | -65.7M | -58.34M | -66.72M | -57.76M | -54.4M | -42.98M | -44.25M | -50.12M | -34.52M | -40.18M |
Net Income | -68.92M | -61.33M | -60.33M | -66.72M | -69.65M | -62.05M | -59.66M | -61.9M | -65.7M | -54.94M | -64.36M | -57.02M | -54.59M | -43.4M | -44.25M | -50.12M | -34.52M | -40.18M |
Selling & General & Admin | 25.02M | 28.45M | 25.34M | 27.11M | 26.58M | 21.36M | 21.54M | 18.59M | 17.37M | 15.82M | 19.05M | 15.11M | 12.85M | 11.77M | 12.17M | 9.67M | 9.25M | 10.68M |
Research & Development | 42.66M | 35.94M | 37.36M | 42.31M | 44.79M | 43.76M | 41.74M | 46.84M | 51.38M | 46.37M | 50.04M | 43.38M | 41.36M | 30.79M | 32.16M | 39.98M | 24.8M | 28.54M |
Other Expenses | 3.47M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -500K | n/a | n/a | n/a | -500K | n/a | n/a | 500K |
Operating Expenses | 71.15M | 64.39M | 62.69M | 69.42M | 71.37M | 65.12M | 63.28M | 65.43M | 68.76M | 62.19M | 68.58M | 58.49M | 54.21M | 42.56M | 43.83M | 49.65M | 34.05M | 38.72M |
Interest Expense | 473K | 472K | 473K | 471K | 471K | 471K | 470K | 469K | 468K | 468K | 467K | 621K | 861K | 1.04M | 1.26M | 1.28M | 978K | 1.73M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -786K | -787K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 71.15M | 64.39M | 62.69M | 69.42M | 73.71M | 67.38M | 63.28M | 65.43M | 68.76M | 62.19M | 68.58M | 58.49M | 54.21M | 42.56M | 43.83M | 49.65M | 34.05M | 38.72M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.39M | -2.36M | -732K | 192K | 418K | n/a | n/a | 251K | n/a |
Shares Outstanding (Basic) | 111.02M | 110.09M | 97.53M | 94.16M | 93.75M | 93.55M | 93.34M | 82.64M | 80.47M | 79.45M | 72.89M | 66.22M | 65.48M | 64.51M | 64.47M | 63.83M | 63.06M | 61.57M |
Shares Outstanding (Diluted) | 111.02M | 110.09M | 97.53M | 94.16M | 93.75M | 93.55M | 93.34M | 82.64M | 80.47M | 79.45M | 72.89M | 66.22M | 65.48M | 64.51M | 64.47M | 63.83M | 63.06M | 61.57M |
EPS (Basic) | -0.62 | -0.56 | -0.62 | -0.71 | -0.74 | -0.66 | -0.64 | -0.75 | -0.82 | -0.69 | -0.88 | -0.86 | -0.83 | -0.67 | -0.69 | -0.79 | -0.55 | -0.65 |
EPS (Diluted) | -0.62 | -0.56 | -0.62 | -0.71 | -0.74 | -0.66 | -0.64 | -0.75 | -0.82 | -0.69 | -0.88 | -0.86 | -0.83 | -0.67 | -0.69 | -0.79 | -0.55 | -0.65 |
EBITDA | -65.87M | -57.87M | -57.49M | -63.86M | -66.84M | -59.33M | -56.82M | -59.67M | -63.51M | -56.19M | -64.98M | -55.66M | -52.37M | -41.22M | -41.1M | -48.78M | -32.84M | -37.78M |
EBIT | -68.45M | -60.86M | -59.85M | -66.25M | -69.17M | -61.58M | -59.19M | -61.43M | -65.23M | -57.87M | -66.75M | -57.13M | -53.54M | -41.94M | -44.28M | -48.84M | -33.55M | -37.81M |
Depreciation & Amortization | 2.58M | 2.99M | 2.36M | 2.39M | 2.34M | 2.25M | 2.37M | 1.76M | 1.72M | 1.67M | 1.78M | 1.64M | 1.57M | 1.3M | 3.19M | 800K | 700K | 674K |